Wednesday, September 15, 2010

Vol. 16, No. 18

TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 16, No. 18  September 15, 2010
(The next issue will be on October 1, 2010)
__________________________________________________________
TRIGGER is also available by RSS Feed:
http://feeds.feedburner.com/blogspot/glro
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
ANNOUNCEMENTS
Some companies have asked us to include announcements of research products in TRIGGER that would be of interest to our subscribers. We have agreed to do this, free of charge, with ground rules that are available on the TRIGGER web site:
http://tf7.org/product_info.html

Please note that everything about TRIGGER (subscribing, placing product announcements, etc.) is free and that the editors receive no remuneration for any aspect of publishing TRIGGER.
__________________________________________________________
PRODUCT ANNOUNCEMENT
Haematologic Technologies, Inc. supplies a full range of purified proteins and antibodies for use in thrombosis research. These proteins include:


Contact customer service (hti AT haemtech DOT com) for additional information, or simply visit our website via the links above. Please include "Trigger" in the subject line.

DISCLAIMER: Commercial product announcements appearing in TRIGGER are provided "as is" for informational purposes only. The editors of TRIGGER have not necessarily evaluated any materials from commercial suppliers described in this newsletter or on its web sites, and we certainly are not endorsing any specific suppliers or products. Furthermore, the editors receive no revenues from any source in the course of publishing TRIGGER.
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1de12h8bJo256khgO-cbu6i/

Bae JS, Yang L, and Rezaie AR (2010) Factor X/Xa elicits protective signaling responses in endothelial cells directly via PAR-2 and indirectly via EPCR-dependent recruitment of PAR-1. J Biol Chem
http://www.ncbi.nlm.nih.gov/pubmed/20826780

Berntorp E, Collins P, D'Oiron R, Ewing N, Gringeri A, Negrier C, and Young G (2010) Identifying non-responsive bleeding episodes in patients with haemophilia and inhibitors: a consensus definition. Haemophilia
http://www.ncbi.nlm.nih.gov/pubmed/20825500

Criddle LM (2010) Recombinant factor VIIa and the patient with neurologic bleeding: separating fact from fiction. J Neurosci Nurs 42:229-234
http://www.ncbi.nlm.nih.gov/pubmed/20804119

Matevosyan K, Madden C, Barnett SL, Beshay JE, Rutherford C, and Sarode R (2010) Coagulation factor levels in neurosurgical patients with mild prolongation of prothrombin time: effect on plasma transfusion therapy. J Neurosurg
http://www.ncbi.nlm.nih.gov/pubmed/20815699

Michalska-Krzanowska G (2010) [Recombinant factor VIIa for treatment of postpartum hemorrhage due to uterine atony]. Ginekol Pol 81:544-548.
http://www.ncbi.nlm.nih.gov/pubmed/20825059

Mu E, Liu X, Chen S, Zhi L, Li X, Xu X, and Ma X (2010) Changes in factor VII-activating protease in a bleomycin-induced lung injury rat model and its influence on human pulmonary fibroblasts in vitro. Int J Mol Med 26:549-555.
http://www.ncbi.nlm.nih.gov/pubmed/20818495

Schwarz H, Stephan S, Sidelmann JJ, Fischer B, Althaus H, Hahn M, Kappel A, Ehm M, and Vitzthum F (2010) Qualitative detection of the Marburg I alloenzyme of factor VII-activating protease by an immunoassay and its comparison to PCR testing. Clin Chem Lab Med
http://www.ncbi.nlm.nih.gov/pubmed/20828365

Tetik S, Ak K, Sahin Y, Gulsoy O, Isbir S, Arsan S, and Yardimci T (2010) Postoperative statin therapy attenuates the intensity of systemic inflammation and increases fibrinolysis after coronary artery bypass grafting. Clin Appl Thromb Hemost
http://www.ncbi.nlm.nih.gov/pubmed/20805103

West KL, Adamson C, and Hoffman M (2010) Prophylactic correction of the international normalized ratio in neurosurgery: a brief review of a brief literature. J Neurosurg
http://www.ncbi.nlm.nih.gov/pubmed/20815695
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.

DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________
Posted by at No comments:
Subscribe to: Posts (Atom)